Month: July 2021

Healthcare and financial services industry veteran brings nearly 15 years of multi-disciplinary financial experience and proven track record in strategic investments, equity capital markets, and partnershipsSean GrantCFO, Vera TherapeuticsSOUTH SAN FRANCISCO, Calif., July 14, 2021 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Sean Grant, MBA as Chief Financial Officer. In this role, he will oversee all of Vera Therapeutics’ financial operations including financial strategy, investor relations, accounting operations, financial planning and analysis, tax, and treasury. Marshall Fordyce, MD, founder and CEO of...

NEW YORK, July 14, 2021 (GLOBE NEWSWIRE) — BeyondSpring (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global pharmaceutical company focused on the development of cancer therapeutics, today announced the appointment of Brendan Delaney to its Board of Directors, effective immediately. Mr. Delaney brings his significant expertise in commercial oncology drug launches. BeyondSpring’s lead developmental asset, plinabulin, is currently under Priority Review by the U.S. Food and Drug Administration (FDA) for the prevention of chemotherapy-induced neutropenia (CIN) with a U.S. Prescription Drug User Fee Act (PDUFA) action date of November 30, 2021. Mr. Delaney is expected to play an important role in the commercial launch planning for plinabulin and implementation, pending successful regulatory review. “We couldn’t be...

TORONTO and CHICAGO, July 14, 2021 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced the addition of Ian Burnstein to its Scientific Advisory Board. In this role, Burnstein will provide strategic guidance and direction to Wesana’s executive team, footprint expansion efforts, and overall company efforts related to the research and treatment of traumatic brain injury (TBI). Burnstein brings a deep understanding of investment strategies, entrepreneurship, market knowledge, and philanthropy. He is the principal and co-founder of Equitable Advisors,...

Figure 1Off Channel Reservoir MiningFigure 2New Nobsin River Bridge CrossingFigure 3Fuel Storage Area under constructionFigure 4Surface Water Management Pond under constructionFigure 5Orezone hosts the Burkina Faso Minister of Energy and Mines, and Coris Bank at Bomboré, June 2021VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX.V: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to provide an update on construction progress at its Bomboré Gold Project in Burkina Faso. Patrick Downey, President and CEO stated, “Significant progress has been achieved during the first half of 2021 and I am very pleased to report that the project capital cost remains consistent with the estimate in the 2019 Feasibility...

Company to transition all portfolio programs to rapid enzymatic synthesis (RES), enabling improved quality, scale and speed of closed-ended DNA manufacturing Lease agreement signed to build an in-house RES manufacturing facility providing cGMP capacity for and internal control over clinical and initial commercial supply IND submission for hemophilia A now planned for 2023; factor VIII expression data with RES material in non-human primates expected year-end 2021 CAMBRIDGE, Mass., July 14, 2021 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced today that it plans to deploy next-generation rapid enzymatic synthesis (RES) for manufacturing of its closed-ended DNA (ceDNA) constructs across all portfolio programs. RES...

ROCHESTER, N.Y., July 14, 2021 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, will release its fiscal 2022 first quarter earnings on July 28, 2021. The Company will host a conference call and audio webcast on Wednesday, July 28, 2021 at 8:30 a.m. Eastern Time. The conference call may be accessed by dialing 1-877-425-9470 and using the required passcode 13721510. A replay will be available approximately two hours after the recording through Wednesday, August 11, 2021 and can be accessed by dialing 1-844-512-2921 and using the required passcode of 13721510. The live conference call and replay can also be accessed via audio webcast at the Investors section of the Company’s website, located at corporate.monro.com. An archive will be available at this website through...

Life Clips plans to enter the $2 trillion cryptocurrency market by acquiring Belfrics Group AVENTURA, Fla., July 14, 2021 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”, “Life Clips”), announced today it has agreed to acquire Belfrics Group (“Belfrics”), a global blockchain technology firm that runs cryptocurrency exchanges on its proprietary platform. Belfrics currently has a presence in Malaysia, Singapore, India, Kenya, Tanzania, Nigeria, and Bahrain; and it has the capability to process over 1 million transactions per second. Belfrics CEO and Founder, Praveen Kumar, will remain the CEO of Belfrics, while Robert Grinberg will serve as CEO of Life Clips. The cryptocurrency market is expected to reach $8 trillion dollars by 2030, while the market for blockchain technology is expected to add $176...

VANCOUVER, British Columbia, July 14, 2021 (GLOBE NEWSWIRE) — ParcelPal Logistics Inc. (the “Company” or “ParcelPal”), (OTC:PTNYF) (CSE:PKG) (FSE:PT0) is pleased to announce that it has signed a “letter of intent” with a United States delivery service company (“Acquiree”). In its most recent fiscal year 2020, Acquiree generated gross revenues of approximately $4.6M USD. The total purchase price (the “Purchase Price”) is expected to be $3.1 million USD, payable in cash (60%) and in restricted shares of ParcelPal common stock (40%, which shall be priced at-market based on the closing price of the common stock following the closing of the transaction).   Under the terms of the proposed transaction, ParcelPal will acquire 95% of the outstanding shares of Acquiree’s capital stock, and Acquiree will enter into an exclusive services agreement...